Premium
Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single centre experience
Author(s) -
Woltsche N.,
Pichler N.,
Wolf I.,
Di Meo N.,
Zalaudek I.
Publication year - 2019
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.15367
Subject(s) - vismodegib , medicine , basal cell carcinoma , hedgehog , hedgehog signaling pathway , adverse effect , basal cell , basal (medicine) , oncology , reduction (mathematics) , biochemistry , chemistry , signal transduction , geometry , mathematics , insulin , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom